Winton Group’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-72,465
| Closed | -$340K | – | 794 |
|
|
2024
Q3 | $340K | Sell |
72,465
-41,018
| -36% | -$192K | 0.02% | 498 |
|
|
2024
Q2 | $641K | Sell |
113,483
-50,343
| -31% | -$284K | 0.04% | 389 |
|
|
2024
Q1 | $673K | Buy |
163,826
+50,734
| +45% | +$209K | 0.05% | 428 |
|
|
2023
Q4 | $477K | Buy |
113,092
+25,599
| +29% | +$108K | 0.03% | 339 |
|
|
2023
Q3 | $378K | Buy |
87,493
+2,293
| +3% | +$9.91K | 0.03% | 433 |
|
|
2023
Q2 | $561K | Buy |
85,200
+19,331
| +29% | +$127K | 0.05% | 276 |
|
|
2023
Q1 | $447K | Sell |
65,869
-5,093
| -7% | -$34.6K | 0.03% | 729 |
|
|
2022
Q4 | $524K | Buy |
70,962
+17,585
| +33% | +$130K | 0.03% | 611 |
|
|
2022
Q3 | $527K | Sell |
53,377
-23,805
| -31% | -$235K | 0.03% | 628 |
|
|
2022
Q2 | $841K | Buy |
77,182
+59
| +0.1% | +$643 | 0.04% | 536 |
|
|
2022
Q1 | $872K | Buy |
77,123
+20,101
| +35% | +$227K | 0.05% | 513 |
|
|
2021
Q4 | $895K | Sell |
57,022
-13,270
| -19% | -$208K | 0.05% | 499 |
|
|
2021
Q3 | $1.21M | Sell |
70,292
-11,286
| -14% | -$193K | 0.07% | 408 |
|
|
2021
Q2 | $1.76M | Sell |
81,578
-8,329
| -9% | -$179K | 0.09% | 236 |
|
|
2021
Q1 | $1.35M | Sell |
89,907
-9,050
| -9% | -$136K | 0.08% | 307 |
|
|
2020
Q4 | $1.3M | Sell |
98,957
-178,244
| -64% | -$2.34M | 0.09% | 278 |
|
|
2020
Q3 | $2.68M | Sell |
277,201
-308,047
| -53% | -$2.98M | 0.09% | 391 |
|
|
2020
Q2 | $6.7M | Buy |
585,248
+21,725
| +4% | +$249K | 0.17% | 121 |
|
|
2020
Q1 | $5.84M | Buy |
563,523
+10,883
| +2% | +$113K | 0.15% | 189 |
|
|
2019
Q4 | $9.07M | Buy |
552,640
+529,686
| +2,308% | +$8.69M | 0.13% | 269 |
|
|
2019
Q3 | $305K | Buy |
+22,954
| New | +$305K | ﹤0.01% | 1274 |
|